Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse.

  • Published 1999 in Prescrire international

Abstract

(1) Naltrexone is an opiate receptor antagonist licensed for the maintenance of alcohol abstinence after withdrawal. (2) The clinical file in this indication is limited to three placebo-controlled trials lasting three months. (3) The results show that naltrexone prevents the resumption of alcohol consumption during treatment, but a post-trial follow-up… (More)

Topics

Cite this paper

@article{1999NaltrexoneNP, title={Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse.}, author={}, journal={Prescrire international}, year={1999}, volume={8 39}, pages={9-11} }